Vaccines

A new, adaptable antibody, has been discovered by researchers at the Dana-Farber Cancer Institute that can mutate to neutralize a number of influenza strains.

Walgreens has partnered up again with the US Department of Health in an effort to improve rates of flu vaccination by providing over $10 million in free flu shot vouchers for Americans who are uninsured.

Nearly 900,000 people in the United States get pneumococcal pneumonia each year, resulting in about 400,000 hospitalizations annually.

An anxiously awaited vaccine for the fight against Zika may be available sooner rather than later—if its developers and federal health officials get their way.

Micaela Martinez, PhD, postdoctoral fellow in the Department of Ecology and Evolutionary Biology at Princeton University, discusses how vector seasonality can potentially be used to eradicate polio worldwide.

The US Food and Drug Administration (FDA) has approved the new influenza vaccines AFLURIA and AFLURIA QUADRIVALENT from Seqirus.

Micaela Martinez, PhD, postdoctoral fellow in the Department of Ecology and Evolutionary Biology at Princeton University, discusses how the poliovirus has not yet been eradicated despite preventive measures and deadlines.

A new study found that parents are more likely to support making human papillomavirus (HPV) vaccinations mandatory for school enrollment, if they are able to opt-out.

A new model of the within-host evolutionary arms race between viral pathogens and the adaptive immune responses intended to fight them suggests that vaccines based on genetically diverse sets of viral antigens may be more likely to stimulate the production of antibodies capable of neutralizing broad panels of virions.

Chlamydia has posed a healthcare challenge for clinicians due to the serious complications associated with it.

Researchers at St. Jude Children’s Research Hospital discovered that adjuvanted flu vaccines do not protect obese mice as they do their lean counterparts from flu infection.

Engineers at the Massachusetts Institute of Technology have developed a new type of customizable vaccines using messenger RNA that has proven to effectively combat a wide range of lethal pathogens when administered to mice, and might be able to reduce disease outbreak response time in the future.

An international team of researchers has identified a potential role for certain monoclonal antibodies in developing a treatment for Zika virus.

Investigators at the National Institute of Allergy and Infectious Diseases (NIAID) and the National Human Genome Research Institute (NHGRI) believe they have found the key to developing a universal vaccine for influenza.

The Hawaii State Department has confirmed an open investigation of the hepatitis A infection in Oahu, Hawaii.

The number of confirmed cases in the outbreak has been attributed to the reluctance of some to be vaccinated.

US travelers concerned about contracting cholera during overseas journeys to areas where the disease remains a threat may now have options as they seek to reduce their risk.

A recent review focuses on the biology of human papillomaviruses, their associated burdens, and the clinical data available on HPV vaccine efficacy.

A recent review article on the status of vaccines in development for healthcare associated infections (HAIs) provides both an in-depth discussion of their urgent need, as well as their potential for success.

Management of visceral leishmaniasis poses a daunting challenge, in part due to the side effects associated with the use of the traditional treatment. However, one vaccine development strategy has recently shown promising results.

The number of expecting mothers who opt for annual vaccination for influenza during pregnancy remains relatively low; however, the results of a new study suggest this may be changing—and that there are obvious benefits for immunization for newborns.

Rohit Bhalla, DO, Chief of the Section of Infectious Diseases at the University Medical Center of Princeton, discusses if we will see more vaccine-preventable diseases in the United States in the future.

Rohit Bhalla, DO, Chief of the Section of Infectious Diseases at the University Medical Center of Princeton, shares how healthcare practitioners can help stop the spread of mumps.

Dr. Rohit Bhalla, DO, Chief of the Section of Infectious Diseases at the University Medical Center of Princeton, explains why an individual could still become infected with mumps, even after receiving vaccinations.

A recent review article on the status of influenza vaccines, their short-comings, and ways to improve them suggests the potential for significant improvements in the performance of future influenza vaccines.